Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin vs Clopidogrel for Immune Activation in Chronic HIV
NCT02578706Phase 2Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Oct 2015
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin, clopidogrel in human immunodeficiency virus infection (HIV), sponsored by Icahn School of Medicine at Mount Sinai. Started Oct 2015; status: completed.
02
Drugs
aspirinclopidogrel
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02578706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02578706.